McKesson Co. (NYSE:MCK - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the sixteen brokerages that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $646.14.
A number of equities research analysts have issued reports on MCK shares. Deutsche Bank Aktiengesellschaft cut their price target on McKesson from $623.00 to $579.00 and set a "buy" rating for the company in a research note on Wednesday, September 25th. Citigroup decreased their price target on shares of McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Robert W. Baird upgraded McKesson from a "neutral" rating to an "outperform" rating and lifted their price target for the stock from $531.00 to $688.00 in a research report on Thursday, November 7th. Baird R W upgraded McKesson from a "hold" rating to a "strong-buy" rating in a research report on Thursday, November 7th. Finally, Bank of America dropped their target price on McKesson from $680.00 to $650.00 and set a "buy" rating for the company in a report on Monday, January 6th.
Read Our Latest Analysis on MCK
McKesson Stock Performance
Shares of NYSE:MCK opened at $592.69 on Tuesday. The stock has a market capitalization of $75.24 billion, a price-to-earnings ratio of 30.69, a PEG ratio of 1.26 and a beta of 0.52. The stock's 50-day simple moving average is $595.11 and its two-hundred day simple moving average is $561.01. McKesson has a 52-week low of $464.42 and a 52-week high of $637.51.
McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.88 by $0.19. The company had revenue of $93.65 billion for the quarter, compared to the consensus estimate of $89.33 billion. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. McKesson's quarterly revenue was up 21.3% compared to the same quarter last year. During the same period in the previous year, the business earned $6.23 earnings per share. As a group, equities analysts forecast that McKesson will post 32.73 earnings per share for the current fiscal year.
McKesson Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Monday, December 2nd were given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date of this dividend was Monday, December 2nd. McKesson's dividend payout ratio (DPR) is presently 14.71%.
Insider Transactions at McKesson
In related news, EVP Leann B. Smith sold 579 shares of the company's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total value of $331,645.41. Following the completion of the sale, the executive vice president now directly owns 864 shares of the company's stock, valued at $494,890.56. This represents a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.11% of the company's stock.
Institutional Investors Weigh In On McKesson
Several hedge funds have recently modified their holdings of the business. Old North State Trust LLC lifted its holdings in McKesson by 1.6% during the third quarter. Old North State Trust LLC now owns 1,138 shares of the company's stock worth $563,000 after buying an additional 18 shares during the period. Trust Co. of Vermont lifted its stake in shares of McKesson by 4.8% during the 4th quarter. Trust Co. of Vermont now owns 393 shares of the company's stock worth $224,000 after purchasing an additional 18 shares during the last quarter. Black Diamond Financial LLC boosted its position in McKesson by 1.3% during the third quarter. Black Diamond Financial LLC now owns 1,525 shares of the company's stock valued at $754,000 after purchasing an additional 19 shares in the last quarter. QV Investors Inc. grew its stake in McKesson by 0.6% in the third quarter. QV Investors Inc. now owns 3,499 shares of the company's stock valued at $1,730,000 after purchasing an additional 20 shares during the last quarter. Finally, ASB Consultores LLC raised its holdings in McKesson by 2.4% in the third quarter. ASB Consultores LLC now owns 879 shares of the company's stock worth $435,000 after purchasing an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company's stock.
About McKesson
(
Get Free ReportMcKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Stories
Before you consider McKesson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.
While McKesson currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.